Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Effect (Details) - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares of common stock equivalents (in shares) | 13,812,799 | 8,405,372 |
| Options to purchase common stock | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares of common stock equivalents (in shares) | 10,964,703 | 8,405,372 |
| Purchase warrants | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total shares of common stock equivalents (in shares) | 2,848,096 | 0 |